Prelude Capital Management’s Protara Therapeutics TARA Stock Holding History

Prelude Capital Management’s Portfolio TARA Stock Details TARA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$93.6K	Sell
2025 Q2	$69.1K	Buy
2022 Q2	–	Sell
2022 Q1	$66K	Sell
2021 Q4	$114K	Buy
2021 Q3	$91K	Buy
2021 Q2	$114K	Buy
2018 Q1	–	Sell
2017 Q4	$9K	Buy